| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| SC Capital II Sponsor LLC | 10%+ Owner | 575 FIFTH AVENUE, 14TH FLOOR, NEW YORK | /s/ Menachem Shalom as Authorized Signatory of SC Capital II Sponsor LLC | 25 Nov 2025 | 0002076738 |
| Nukkleus Defense Technologies, Inc. | 10%+ Owner | 575 FIFTH AVENUE, 14TH FLOOR, NEW YORK | /s/ Menachem Shalom as CEO of Nukkleus Defense Technologies, Inc., the managing member of the Sponsor | 25 Nov 2025 | 0002095058 |
| Nukkleus Inc. | 10%+ Owner | 575 FIFTH AVENUE, 14TH FLOOR, NEW YORK | /s/ Menachem Shalom as CEO of Nukkleus, Inc. | 25 Nov 2025 | 0001787518 |
| Shalom Menachem | CEO, Director | 575 FIFTH AVENUE, 14TH FLOOR, NEW YORK | /s/ Menachem Shalom | 25 Nov 2025 | 0002030245 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| holding | SCII | Class B Ordinary Shares | 25 Nov 2025 | Class A Ordinary Shares | 7,392,857 | Direct | F1, F2, F3 |
| Id | Content |
|---|---|
| F1 | As described in the registration statement on Form S-1 (File No. 333-290917) of SC II Acquisition Corp. (the "Issuer") under the heading "Description of Securities--Founder Shares," the shares of Class B ordinary shares will automatically convert into shares of Class A ordinary shares at the time of the Issuer's initial business combination, or at any time prior to the Issuer's initial business combination, at the option of the holder, on a one-for-one basis, subject to certain adjustments. The Class B ordinary shares have no expiration date. |
| F2 | These shares represent the Class B ordinary shares held by SC Capital II Sponsor LLC (the "Sponsor") acquired pursuant to a subscription agreement by and between the Issuer and the Sponsor. The Class B ordinary shares include up to 964,286 shares that are subject to forfeiture in the event the underwriters of the Issuer's initial public offering do not exercise in full their over-allotment option as described in the Issuer's registration statement. |
| F3 | The Sponsor is the record holder of the Class B ordinary shares reported herein. The sole managing member of the Sponsor is Nukkleus Defense Technologies, Inc., a Nevada corporation (the "Managing Member"), which is a subsidiary of Nukkleus, Inc., a Delaware corporation ("Nukkleus"). Mr. Menachem Shalom is the Chief Executive Officer and a director of the Issuer, is the Chief Executive Officer and sole director of the Managing Member and is the Chief Executive Officer and a director of Nukkleus. Mr. Shalom serves as the Chief Executive Officer and sole director of the Managing Member at the discretion of the Board of Directors of Nukkleus. Mr. Shalom, solely in his capacity as Chief Executive Officer and sole director of the Managing Member, has voting and dispositive control over the Class B ordinary shares held by the Sponsor and reported hereunder. Mr. Shalom disclaims beneficial ownership to these securities other than to the extent that he has a pecuniary interest therein. |